Innovation in healthcare is hindered by the time and cost of bringing new therapeutics and devices to market. Verana Health (fka DigiSight Technologies) is building a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets. This platform initially utilizes real-world data from the world’s largest clinical database in ophthalmology, representing billions of data points, to deeply understand patient needs and to optimize drug and device development from clinical research through to post-commercialization.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/12/15 | $7,800,000 | Series B |
Biosys Capital GE Ventures Lagunita Waycross Ventures | undisclosed |
| 07/31/18 | $30,000,000 | Series C |
Biomatics Capital Brook Byers GE Ventures Lagunita Biosciences | undisclosed |
| 01/14/22 | $150,000,000 | Series E |
Breyer Capital Brook Byers Casdin Capital GV Johnson & Johnson Development Corporation (JJDC)  Merck Global Health Innovation Fund Novo Holdings THVC | undisclosed |
